Clinical Research Directory

Browse clinical research sites, groups, and studies.

Sites Groups Studies

Back to Studies

RECRUITING

NCT06282510

PHASE4

Nasal Antisepsis for C. Auris Prevention

Sponsor: Mary K Hayden

View on ClinicalTrials.gov

Summary

This is a randomized, controlled, open-label trial of effect of 10% povidone iodine intranasal antisepsis on the detection of Candida auris.

Official title: Impact of Nasal Antisepsis on Candida Auris Colonization

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

120

Start Date

2024-01-29

Completion Date

2028-12

Last Updated

2025-10-15

Healthy Volunteers

Conditions

Candida Auris Infection Colonization, Asymptomatic

Interventions

DRUG

Povidone Iodine Topical

Topical intranasal povidone iodine (10%) twice daily for 5 days

Locations (3)

Rush University Medical Center

Chicago, Illinois, United States

RML Specialty Hospital